CD46 and plasma cell myeloma: Notably, CD46 expression is increased up to 14-fold in relapsed multiple myeloma (MM) patients who have the region on chromosome 1q carrying CD46 genomically amplified (mean antigen density 313,190 for MM vs. 22,475 for healthy donor plasma cells) [20].